# Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS

> **NCT02200952** · — · COMPLETED · sponsor: **San Carlo Public Hospital, Potenza, Italy** · enrollment: 16 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** recombinant LH

## Key facts

- **NCT ID:** NCT02200952
- **Lead sponsor:** San Carlo Public Hospital, Potenza, Italy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-30
- **Primary completion:** 2014-06-30
- **Final completion:** 2014-06-30
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200952, "Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02200952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*